DT: Writing original draft, Writing review and editing
Back Nielsen, HK, DeChiaro, S, Goldman, B (31 May 2021) 'Evaluation of consistency of treatment response across regionsthe LEADER trial in relation to the ICH E17 guideline' , Frontiers, Sec
In: Office of disease prevention and health promotion USDoHaHS, ed
The mechanism involves inhibition of catechol-O-methyltransferase (COMT), which extends norepinephrine activity and slightly increases metabolic rate
In the hyperglycemic clamping experiment, cotadutide was also found to reduce the de novo fat production of the liver during clamping
In fact, it suppressed the bodys own GLP-1 production from its already-low levels, so when you stop it the inevitable happens